Pro Medicus Limited (PMCUF)

Market Cap	8.47B -45.9%
Revenue (ttm)	160.46M +30.3%
Net Income	156.55M +138.8%
EPS	1.50 +138.7%
Shares Out	n/a
PE Ratio	54.09
Forward PE	70.68
Dividend	0.42 (0.50%)
Ex-Dividend Date	Feb 26, 2026

Volume	42
Average Volume	676
Open	84.00
Previous Close	84.50
Day's Range	84.00 - 84.00
52-Week Range	74.52 - 218.25
Beta	0.49
RSI	40.39
Earnings Date	May 13, 2026

About Pro Medicus

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and commu...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1983
• Employees: 132
• Stock Exchange: OTCMKTS
• Ticker Symbol: PMCUF

Financial Performance

In fiscal year 2025, Pro Medicus's revenue was 212.98 million, an increase of 31.88% compared to the previous year's 161.50 million. Earnings were 115.22 million, an increase of 39.16%.

Financial numbers in AUD